Insider · CIK 0001203603
Jack E Stover
Files at TRAW (Traws Pharma, Inc.), PFSA (Profusa, Inc.). First filing -, latest -.
In brief
Jack E Stover files SEC Form 4 as CEO and director at TRAW (Traws Pharma, Inc.), and also at PFSA (Profusa, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jack E Stover has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | PFSA Profusa, Inc. | JOther Common Stock | +32,018 | $0.00 | $0 | 32,091 | 39 d ago |
| Aug 21, 2026 | PFSA Profusa, Inc. | JOther Common Stockindirect: By NorthView Sponsor I LLC | -301,991 | $0.00 | $0 | 0 | 39 d ago |
| Aug 12, 2026 | PFSA Profusa, Inc. | CConversion Common Stockindirect: By NorthView Sponsor I LLC | +301,991 | $4.28 | $1.3M | 301,991 | Aug 19, 2026 |
| Aug 12, 2026 | PFSA Profusa, Inc. | CConversion Convertible Promissory Notederivativeindirect: By NorthView Sponsor I LLC | - | $0.00 | - | - | Aug 19, 2026 |
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,150 | $0.00 | $0 | 14,150 | Jul 14, 2026 |
| May 4, 2026 | PFSA Profusa, Inc. | POpen-market purchase Convertible Promissory Notederivativeindirect: By NorthView Sponsor I LLC | - | $1,869,796.00 | - | - | May 6, 2026 |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +33,435 | $0.00 | $0 | 33,435 | Mar 10, 2026 |
| Jan 26, 2026 | PFSA Profusa, Inc. | JOther Common Stock | +553,665 | - | - | 553,665 | Jan 30, 2026 |
| Jan 26, 2026 | PFSA Profusa, Inc. | JOther Warrantsderivative | +380,280 | $0.00 | $0 | 380,280 | Jan 30, 2026 |
| Jan 26, 2026 | PFSA Profusa, Inc. | AGrant or award Stock Optionsderivative | +221,794 | $0.00 | $0 | 221,794 | Jan 29, 2026 |
| Jan 26, 2026 | PFSA Profusa, Inc. | AGrant or award Stock Optionsderivative | +52,866 | $0.00 | $0 | 52,866 | Jan 29, 2026 |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Common Stock | +6,157 | $0.00 | $0 | 6,165 | Dec 16, 2025 |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to purchase)derivative | +24,629 | $0.00 | $0 | 24,629 | Dec 16, 2025 |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to purchase)derivative | +11,530 | $0.00 | $0 | 11,530 | Oct 15, 2025 |
| Jun 19, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to purchase)derivative | +23,000 | $0.00 | $0 | 23,000 | Jun 23, 2025 |
Questions about Jack E Stover
Answered from the filings on this page, as of the latest one.
Is Jack E Stover buying or selling?
Jack E Stover has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jack E Stover's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jack E Stover has 0.
Where does Jack E Stover file Form 4?
Jack E Stover has filed Form 4 at TRAW (Traws Pharma, Inc.); PFSA (Profusa, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.